Vitamin D Supplement Could Impact Diabetes Risk, But Evidence Is Contradictory
Renowned epidemiologist Professor Tim Spector has highlighted that a widely used dietary supplement might influence the likelihood of developing a serious metabolic condition. According to his insights, regular intake of vitamin D pills could potentially decrease the risk of type 2 diabetes. However, he emphasised that scientific understanding remains incomplete, with studies presenting mixed outcomes on its efficacy.
Evolving Perspectives on Vitamin D and Bone Health
During a recent episode of the Zoe Science and Nutrition podcast, Prof Spector, founder of the health science company Zoe, traced the shifting scientific consensus on vitamin D. He recalled initially advocating for its use in osteoporosis prevention, a condition characterised by weakened and brittle bones. Early research appeared promising, but larger-scale studies focusing on fracture rates revealed no significant benefit.
"I was a big promoter of vitamin D back in the day for osteoporosis," Prof Spector stated. "The early studies showed that it worked. But when it got to the big studies with fractures, there was no difference. That's why osteoporosis experts now know vitamin D is not useful for preventing fractures in most people."
This view aligns with guidelines from the National Osteoporosis Guideline Group, which notes that while calcium and vitamin D support bone health, evidence for vitamin D supplementation alone reducing fractures is limited, though it may lower fall risks. The Royal Osteoporosis Society also acknowledges vitamin D's role in calcium absorption for bone and muscle strength.
Conflicting Research on Vitamin D and Diabetes
Prof Spector then addressed the potential link between vitamin D and diabetes, remarking, "The latest studies show that it can reduce your risk of getting type 2 diabetes. So it's a really interesting compound, which we still don't fully understand."
A 2020 meta-analysis published in the Diabetes Care journal examined eight trials involving 4,896 participants with prediabetes. It found that vitamin D supplementation significantly lowered the risk of progressing to type 2 diabetes, particularly in non-obese individuals. The study reported that 21.2% of the vitamin D group reverted to normal blood sugar levels, compared to 14.1% in the control group.
Authors concluded that vitamin D reduces type 2 diabetes risk in prediabetic subjects, with benefits most apparent in non-obese populations. They called for further research to identify optimal dosing and subgroups that might benefit most.
Supporting this, a 2025 review in the International Journal of Molecular Sciences noted vitamin D could decrease diabetes likelihood by 15%, especially at doses exceeding standard bone health recommendations. However, it highlighted inconsistencies in study designs and population factors, underscoring the need for personalised approaches.
Conversely, a 2022 review in Cureus found that most studies showed no significant improvement in blood sugar control for type 2 diabetes patients taking vitamin D. Researchers pointed out that while vitamin D might aid glucose metabolism in type 1 diabetes, evidence for type 2 diabetes remains inconclusive, urging more investigation into the exact relationship.
Official Health Recommendations and Safety Guidelines
The NHS advises that vitamin D is essential for maintaining healthy bones, teeth, and muscles, with deficiency leading to conditions like rickets in children and osteomalacia in adults. Since sunlight is the primary source in the UK, the government recommends considering a daily supplement during autumn and winter months.
Current NHS guidance does not mention any connection between vitamin D and diabetes risk. For most people, 10 micrograms daily is sufficient, with a maximum safe limit of 100 micrograms for adults and lower thresholds for children and infants to avoid potential harm.
Prof Spector summarised the broader context, stating, "It's been promoted for a hundred different diseases, and I would say in 98 of them, it's complete rubbish. It’s probably useful if you’re at risk of multiple sclerosis, reduces by a few hours if you take it during a viral infection." This underscores the complexity of vitamin D research and the importance of evidence-based supplementation.
